Literature DB >> 14551727

Patient radiation exposure in uterine artery embolization of leiomyomata: calculation of organ doses and effective dose.

S Vetter1, F W Schultz, E-P Strecker, J Zoetelief.   

Abstract

The goal of this study was estimation of patient effective dose from uterine artery embolization of leiomyomata. Parameters and data relevant to patient dose were recorded for 33 consecutive procedures. Using Monte Carlo simulation of radiation transport, organ and effective doses were calculated in detail for a subset of five procedures, to estimate the effective dose for all procedures. Mean dose area product was 59.9, median 23.4, and range 8.8-317.5 Gycm(2). Mean absorbed ovarian dose was calculated as 51 mGy in the five procedures. Using the dose conversion factor estimated from the Monte Carlo simulation for all procedures a mean estimated effective dose of 34 mSv (median 13 mSv, range 5-182 mSv) results, with a tendency to lower values regarding the succession of the procedures. Patients' radiation exposure level is up to twice of that of an abdominal CT examination. Angiographic equipment related dose-reducing features and radiographic technique essentially influence organ doses and effective dose. Consistent application of dose-reducing techniques and awareness of radiation exposure justifies uterine artery embolization as a therapeutic option for the treatment of uterine fibroids.

Entities:  

Mesh:

Year:  2003        PMID: 14551727     DOI: 10.1007/s00330-003-2088-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  11 in total

1.  Uterine artery embolization: reduced radiation with refined technique.

Authors:  B Nikolic; J B Spies; L Campbell; S M Walsh; S Abbara; M J Lundsten
Journal:  J Vasc Interv Radiol       Date:  2001-01       Impact factor: 3.464

2.  Influence of radiographic technique and equipment on absorbed ovarian dose associated with uterine artery embolization.

Authors:  B Nikolic; S Abbara; E Levy; I Imaoka; M L Lundsten; R C Jha; J B Spies
Journal:  J Vasc Interv Radiol       Date:  2000-10       Impact factor: 3.464

Review 3.  Embolization versus myomectomy versus hysterectomy: which is best, when?

Authors:  Mary Ann Lumsden
Journal:  Hum Reprod       Date:  2002-02       Impact factor: 6.918

4.  Morbidity of 10 110 hysterectomies by type of approach.

Authors:  J Mäkinen; J Johansson; C Tomás; E Tomás; P K Heinonen; T Laatikainen; M Kauko; A M Heikkinen; J Sjöberg
Journal:  Hum Reprod       Date:  2001-07       Impact factor: 6.918

5.  Uterine artery embolization for leiomyomata.

Authors:  J B Spies; S A Ascher; A R Roth; J Kim; E B Levy; J Gomez-Jorge
Journal:  Obstet Gynecol       Date:  2001-07       Impact factor: 7.661

6.  Arterial embolisation to treat uterine myomata.

Authors:  J H Ravina; D Herbreteau; N Ciraru-Vigneron; J M Bouret; E Houdart; A Aymard; J J Merland
Journal:  Lancet       Date:  1995-09-09       Impact factor: 79.321

7.  Patient radiation dose associated with uterine artery embolization.

Authors:  B Nikolic; J B Spies; M J Lundsten; S Abbara
Journal:  Radiology       Date:  2000-01       Impact factor: 11.105

8.  Fibroid-related menorrhagia: treatment with superselective embolization of the uterine arteries and midterm follow-up.

Authors:  J P Pelage; O Le Dref; P Soyer; M Kardache; H Dahan; M Abitbol; J J Merland; J H Ravina; R Rymer
Journal:  Radiology       Date:  2000-05       Impact factor: 11.105

9.  Uterine arterial embolization: factors influencing patient radiation exposure.

Authors:  R T Andrews; P H Brown
Journal:  Radiology       Date:  2000-12       Impact factor: 11.105

10.  Initial results from uterine fibroid embolization for symptomatic leiomyomata.

Authors:  J B Spies; A R Scialli; R C Jha; I Imaoka; S M Ascher; V M Fraga; K H Barth
Journal:  J Vasc Interv Radiol       Date:  1999-10       Impact factor: 3.464

View more
  6 in total

1.  Nanocomposite Carriers for Transarterial Chemoembolization of Liver Cancer.

Authors:  Dong-Hyun Kim; Andrew C Larson
Journal:  Interv Oncol 360       Date:  2016-11-17

2.  Acquired uterine vascular malformations: radiological and clinical outcome after transcatheter embolotherapy.

Authors:  Geert Maleux; Dirk Timmerman; Sam Heye; Guy Wilms
Journal:  Eur Radiol       Date:  2005-06-24       Impact factor: 5.315

3.  Uterine artery embolisation for uterine fibroids using a 4F Rosch inferior mesenteric catheter.

Authors:  Simon S M Ho; Nigel C Cowan
Journal:  Eur Radiol       Date:  2004-10-22       Impact factor: 5.315

4.  Multimodal Imaging of Nanocomposite Microspheres for Transcatheter Intra-Arterial Drug Delivery to Liver Tumors.

Authors:  Dong-Hyun Kim; Weiguo Li; Jeane Chen; Zhuoli Zhang; Richard M Green; Sui Huang; Andrew C Larson
Journal:  Sci Rep       Date:  2016-07-13       Impact factor: 4.379

Review 5.  Uterine artery embolization for treatment of symptomatic fibroids: a review of the evidence.

Authors:  Kavous Firouznia; Hossein Ghanaati; Amir Hossein Jalali; Madjid Shakiba
Journal:  Iran Red Crescent Med J       Date:  2013-12-05       Impact factor: 0.611

6.  Comparing ovarian radiation doses in flat-panel and conventional angiography during uterine artery embolization: a randomized clinical trial.

Authors:  Kavous Firouznia; Hossein Ghanaati; Aliakbar Sharafi; Firouze Abahashemi; Hassan Hashemi; Amir Hossein Jalali; Madjid Shakiba
Journal:  Iran J Radiol       Date:  2013-08-30       Impact factor: 0.212

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.